Early mortality (EM) for newly diagnosed multiple myeloma (NDMM) in the Connect MM U.S. registry.
Howard R. Terebelo
Consultant or Advisory Role - Celgene
Honoraria - Celgene
Jatin J. Shah
Consultant or Advisory Role - Array BioPharma; Celgene; Novartis; Onyx
Research Funding - Array BioPharma; Bristol-Myers Squibb; Celgene; Millennium; Novartis; Onyx
Brian G. Durie
Consultant or Advisory Role - Amgen (U)
Rafat Abonour
Consultant or Advisory Role - Celgene
Honoraria - Celgene; Onyx
Cristina Gasparetto
Consultant or Advisory Role - Celgene
Honoraria - Celgene; Millennium
Other Remuneration - Novartis (I)
Jayesh Mehta
Consultant or Advisory Role - Celgene
Honoraria - Celgene (B); Millennium (B); Takeda (B)
Mohit Narang
Consultant or Advisory Role - Celgene
Sachdev P. Thomas
Consultant or Advisory Role - Celgene
Honoraria - Celgene
Kathleen Toomey
Consultant or Advisory Role - Celgene
Chris L. Pashos
Consultant or Advisory Role - Celgene
Research Funding - Celgene
Arlene S. Swern
Employment or Leadership Position - Celgene
Stock Ownership - Celgene
Kristen A. Sullivan
Employment or Leadership Position - Celgene
Stock Ownership - Celgene
Thomas K. Street
Employment or Leadership Position - Celgene
Stock Ownership - Celgene
Shankar Srinivasan
Employment or Leadership Position - Celgene
Stock Ownership - Celgene
Ali Nourbakhsh
Employment or Leadership Position - Celgene
Stock Ownership - Celgene
James W. Hardin
No relevant relationships to disclose
Robert M. Rifkin
Consultant or Advisory Role - Celgene; Millennium; Onyx; Takeda
Honoraria - Celgene; Millennium; Onyx; Takeda